BRENT WILKINSON: Open Payments
NPI 1891319448 · SOUTH LAKE TAHOE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 99 payments from 19 companies in 2025. Trend: 2023 $290 · 2024 $1,614 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $275 |
| PFIZER INC. | 22 | $224 |
| AstraZeneca Pharmaceuticals LP | 9 | $218 |
| Novo Nordisk Inc | 12 | $164 |
| Corcept Therapeutics | 11 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| Daiichi Sankyo Inc. | 2 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
Products named: NURTEC ODT, Korlym, QULIPTA, ENTYVIO, UBRELVY, JARDIANCE, Ozempic, FARXIGA.
Industry payments across CA — which companies pay providers there.
